References
- Alcorn JF, van der Velden J, Brown AL, et al. (2009). c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol 40:422–32
- Bogoyevitch MA, Kobe B. (2006). Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. MMBR 70:1061–95
- Davis RJ. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103:239–52
- De Borst MH, Prakash J, Melenhorst WB, et al. (2007). Glomerular and tubular induction of the transcription factor c-Jun in human renal disease. J Pathol 213:219–28
- Deponte M. (2013). Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim Biophys Acta 1830:3217–66
- Hashimoto S, Gon Y, Takeshita I, et al. (2001). Transforming growth factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163:152–7
- Hirom PC, Millburn P, Smith RL, Williams RT. (1972). Species variations in the threshold molecular-weight factor for the biliary excretion of organic anions. Biochem J 129:1071–7
- Lim AK, Ma FY, Nikolic-Paterson DJ, et al. (2011). Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats. Am J Nephrol 34:337–46
- Ma FY, Flanc RS, Tesch GH, et al. (2007). A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. JASN 18:472–84
- Molad Y, Amit-Vasina M, Bloch O, et al. (2010). Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 69:175–80
- Plantevin Krenitsky V, Nadolny L, Delgado M, et al. (2012). Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor. Bioorg Med Chem Lett 22:1433–8
- Prakash C, Soliman V. (1997). Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Drug Metab Dispos 25:1288–97
- Reich N, Tomcik M, Zerr P, et al. (2012). Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis. Ann Rheum Dis 71:737–45
- Stepan AF, Walker DP, Bauman J, et al. (2011). Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 24:1345–410
- Tanaka Y, Deguchi Y, Ishii I, Terai T. (1991). Sex differences in excretion of zenarestat in rat. Xenobiotica 21:1119–25